Our laboratory investigates the critical role of the endo-lysosomal system in regulating lipid metabolism and its impact on cardiovascular and liver health. Our research is driven by the pressing need to address cardiovascular disease (CVD), the leading cause of morbidity and mortality worldwide. Our latest discoveries have significantly advanced our understanding of LDLR trafficking, opening new avenues for research in lipid metabolism. However, there is still much to explore in this complex biological system.

The endo-lysosomal network forms a highly dynamic network of interacting membranous compartments. This network is involved in regulating various cellular processes, including lipid metabolism. Our primary focus is on understanding how the endo-lysosomal system controls lipid metabolism, and how this knowledge can be used to combat lipid-related diseases, like atherosclerosis and non-alcoholic fatty liver disease.

Methodologies

To achieve our research goals, we employ cutting edge technologies:

  • CRISPR gene editing technology
  • Transgenic mouse models
  • Primary cell cultures
  • Biochemical studies
  • Advanced imaging techniques  

Key Research Areas

  1. Intracellular lipid trafficking, with a focus on cholesterol
  2. Endocytic pathways controlling cholesterol uptake
  3. Transport of internalized cholesterol between intracellular compartments
  4. Mechanisms of how cellular cholesterol efflux 
  5. Impact metabolic changes on endo-lysosomal network function

Research Focus

We concentrate on:

  • Unraveling the mechanisms by which the endo-lysosomal system regulates plasma and liver lipid levels
  • Exploring how these mechanisms influence the risk of CVD and fatty liver disease
  • Investigating the intracellular trafficking machinery of LDL receptors (LDLR), key determinants of plasma LDL cholesterol concentrations

Potential Impact

By elucidating these intricate cellular processes, our work aims to:

  1. Enhance our understanding of lipid homeostasis
  2. Facilitate the development of novel therapeutic strategies to reduce plasma and liver lipid levels
  3. Contribute to the prevention and treatment of CVD and fatty liver disease

Through our innovative research, we strive to make significant contributions to cardiovascular health and improve patient outcomes in the face of rising CVD prevalence.

Collaborations

We work closely with the team of Jan Albert Kuivenhoven, sharing PhD students and postdocs to foster interdisciplinary research.

Our team has established a state-of-the-art mouse facility to create innovative mouse models, enhancing our fundamental and biomedical research capabilities at UMCG.

Transgenic Mouse Clinic for Ageing Research

Contact

Small profile photo of B. van de Sluis
Bart van de Sluis Professor of Molecular Genetics and Translational Biology

UMCG
Department of Pediatrics (HPC EA12)
Postbus 30.001
9700 RB Groningen
The Netherlands

Visiting address
UMCG
Antonius Deusinglaan 1
3226.0402
9713 AV Groningen
The Netherlands